Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital. https://t.co/kghSDKjnNE
421 followers
403 followers
"Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital" #hpm #EOL https://t.co/SbQ9osZpLR https://t.co/eqbToEDWYl
1,648 followers
This aligns with previous work from @chad_glisch suggesting ICI use near end of life leads to less hospice referrals and more in hospital death. https://t.co/5IuKIJ93tI
501 followers
RT @AmitAryaMD: Immune checkpoint inhibitor therapy should be discontinued when the patient’s functional status is declining. Use in the l…